Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Joint EANM-SNMMI guideline on the role of 2-[18F]FDG PET/CT in no special type breast cancer
69
Zitationen
15
Autoren
2024
Jahr
Abstract
2-[<sup>18</sup>F]FDG PET/CT is extremely useful in BC management, as supported by extensive evidence of its utility compared to other imaging modalities in several clinical scenarios.
Ähnliche Arbeiten
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
2008 · 28.906 Zit.
fastp: an ultra-fast all-in-one FASTQ preprocessor
2018 · 27.820 Zit.
Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma
2005 · 21.257 Zit.
Robust uncertainty principles: exact signal reconstruction from highly incomplete frequency information
2006 · 15.626 Zit.
Image processing with ImageJ
2004 · 11.899 Zit.
Autoren
Institutionen
- Champalimaud Foundation(PT)
- Inserm(FR)
- Délégation Paris 7(FR)
- Université Claude Bernard Lyon 1(FR)
- Hôpital Saint-Louis(FR)
- Université Paris Cité(FR)
- St Thomas' Hospital(GB)
- King's College London(GB)
- University of Southern California(US)
- Hoag Memorial Hospital Presbyterian(US)
- Dana-Farber Cancer Institute(US)
- Harvard University(US)
- Brigham and Women's Hospital(US)
- Dana-Farber Brigham Cancer Center(US)
- Clinica Universidad de Navarra(ES)
- Leiden University Medical Center(NL)
- The Netherlands Cancer Institute(NL)
- Amsterdam University Medical Centers(NL)
- Iridium Kankernetwerk(BE)
- University of Antwerp(BE)
- Radboud University Nijmegen(NL)
- Brown University(US)
- Lifespan(US)
- Providence College(US)
- University of Twente(NL)